HAHelena Aegerter

Helena Aegerter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Helena Aegerter has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intestinal goblet cell loss induces microbiota-independent mucosal and systemic IgA dysregulation

    by Sophie Vanhercke, Alexandra Thiran, Gillian Blancke, Maarten Ciers, Ioanna Petta, Maude Jans, Marie Thorp, Karel F.A. Van Damme, Helena Catherine Aegerter, Vanessa Andries, et al.

    Goblet cells are essential for establishing the intestinal mucus layer and exert diverse immunomodulatory functions. The mucus barrier cooperates with secretory immunoglobulin A (IgA) to regulate host-microbiota interactions and maintain intestinal immune homeostasis. The extent to which goblet cells directly regulate IgA responses remains unclear. Here, we show that depletion of Muc2-expressing intestinal secretory cells in mice caused barrier dysfunction and intestinal inflammation accompanied by profound mucosal and systemic IgA dysregulation, including hyper-IgA, circulating IgA-IgG immune complexes and renal IgA deposition. Selective Paneth cell depletion did not reproduce these IgA abnormalities, and Muc2-deficient mice showed an intermediate phenotype, implicating loss of goblet-cells rather than Paneth cells or of Muc2 loss in this phenotype. Germ-free rederivation markedly attenuated intestinal inflammation but did not prevent mucosal and systemic hyper-IgA or IgA-IgG immune-complex formation, demonstrating that goblet cell loss drives IgA dysregulation independently of live microbial colonisation. Goblet cell loss and IgA deficiency shaped the mucosa-associated microbiota largely independently, as goblet cell depletion promotes expansion of the genus Akkermansia, whereas IgA deficiency reduced Akkermansia but allowed expansion of Mucispirillum and aggravated colonic pathology, indicating that elevated IgA response is partially protective. These findings reveal goblet cells as critical regulators of mucosal and systemic IgA homeostasis beyond mucus production and point to epithelial-immune interactions as potential contributors to IgA-mediated diseases.

  • Open Access

    Ym1 protein crystals promote type 2 immunity

    by Ines Heyndrickx, Kim Deswarte, Kenneth Verstraete, Koen H. G. Verschueren, Ursula Smole, Helena Aegerter, Ann Dansercoer, Hamida Hammad, Savvas N. Savvides, Bart N. Lambrecht

    Spontaneous protein crystallization is a rare event, yet protein crystals are frequently found in eosinophil-rich inflammation. In humans, Charcot-Leyden crystals (CLCs) are made from galectin-10 (Gal10) protein, an abundant protein in eosinophils. Whereas mice do not encode Gal10 in their genome, they do form pseudo-CLCs, made from the chitinase-like proteins Ym1 and/or Ym2, encoded by Chil3 and Chil4 and made by myeloid and epithelial cells respectively. Here, we investigated the biological effects of pseudo-CLCs since their function is currently unknown. We produced recombinant Ym1 crystals which were shown to have identical crystal packing and structure by X-ray crystallography as in vivo native crystals derived from murine lung. When administered to the airways of mice, crystalline but not soluble Ym1 stimulated innate and adaptive immunity and acted as a type 2 immune adjuvant for eosinophilic inflammation via triggering of dendritic cells (DCs). Murine Ym1 protein crystals found at sites of eosinophilic inflammation reinforce type 2 immunity and could serve as a surrogate model for studying the biology of human CLCs.


  • Open Access

    Ym1 protein crystals promote type 2 immunity

    by Ines Heyndrickx, Kim Deswarte, Kenneth Verstraete, Koen H. G. Verschueren, Ursula Smole, Helena Aegerter, Ann Dansercoer, Hamida Hammad, Savvas N. Savvides, Bart N. Lambrecht

    Spontaneous protein crystallization is a rare event, yet protein crystals are frequently found in eosinophil-rich inflammation. In humans, Charcot-Leyden crystals (CLCs) are made from galectin-10 (Gal10) protein, an abundant protein in eosinophils. Whereas mice do not encode Gal10 in their genome, they do form pseudo-CLCs, made from the chitinase-like proteins Ym1 and/or Ym2, encoded by Chil3 and Chil4 and made by myeloid and epithelial cells respectively. Here, we investigated the biological effects of pseudo-CLCs since their function is currently unknown. We produced recombinant Ym1 crystals which were shown to have identical crystal packing and structure by X-ray crystallography as in vivo native crystals derived from murine lung. When administered to the airways of mice, crystalline but not soluble Ym1 stimulated innate and adaptive immunity and acted as a type 2 immune adjuvant for eosinophilic inflammation via triggering of dendritic cells (DCs). Murine Ym1 protein crystals found at sites of eosinophilic inflammation reinforce type 2 immunity and could serve as a surrogate model for studying the biology of human CLCs.

  • Open Access

    TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

    by Levi Hoste, Lisa Roels, Leslie Naesens, Victor Bosteels, Stijn Vanhee, Sam Dupont, Cedric Bosteels, Robin Browaeys, Niels Vandamme, Kevin Verstaen, et al.

    In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation syndrome termed multisystem inflammatory syndrome in children (MIS-C). We compared MIS-C immunopathology with severe COVID-19 in adults. MIS-C does not result in pneumocyte damage but is associated with vascular endotheliitis and gastrointestinal epithelial injury. In MIS-C, the cytokine release syndrome is characterized by IFNγ and not type I interferon. Persistence of patrolling monocytes differentiates MIS-C from severe COVID-19, which is dominated by HLA-DRlo classical monocytes. IFNγ levels correlate with granzyme B production in CD16+ NK cells and TIM3 expression on CD38+/HLA-DR+ T cells. Single-cell TCR profiling reveals a skewed TCRβ repertoire enriched for TRBV11-2 and a superantigenic signature in TIM3+/CD38+/HLA-DR+ T cells. Using NicheNet, we confirm IFNγ as a central cytokine in the communication between TIM3+/CD38+/HLA-DR+ T cells, CD16+ NK cells, and patrolling monocytes. Normalization of IFNγ, loss of TIM3, quiescence of CD16+ NK cells, and contraction of patrolling monocytes upon clinical resolution highlight their potential role in MIS-C immunopathogenesis.


  • Top Cited Papers

    Protein crystallization promotes type 2 immunity and is reversible by antibody treatment

    by Emma K. Persson, Kenneth Verstraete, Ines Heyndrickx, Elien Gevaert, Helena Aegerter, Jean-Michel Percier, Kim Deswarte, Koen H. G. Verschueren, Ann Dansercoer, Delphine Gras, et al.

    A crystal-clear ingredient for allergy?: Charcot-Leyden crystals (CLCs) are formed from the eosinophil granule protein galectin-10 (Gal10) and found in severe eosinophil-associated diseases like asthma and chronic rhinosinusitis. Whether CLCs actively contribute to disease pathogenesis is unknown. Persson et al. found that lab-grown Gal10 crystals are biosimilar to CLCs (see the Perspective by Allen and Sutherland). When given to mice, the crystals acted as a type 2 adjuvant, mimicking many of the features of human asthma. In contrast, a Gal10 mutein unable to crystallize had no effect. Antibodies against epitopes crucial for Gal10 autocrystallization could dissolve both in vitro–generated Gal10 crystals and patient-derived CLCs. Furthermore, these anti-Gal10 antibodies reversed the effects of Gal10 crystals in a humanized mouse model of asthma, suggesting a potential therapeutic approach for crystallopathies more broadly. Science , this issue p. eaaw4295 ; see also p. 738